Observational studyFrontiers in endocrinology2023
Fibroblast growth factor-23 and cardiovascular disease among prevalent hemodialysis patients focusing on residual kidney function.
Youn Kyung Kee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.